Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §7

CEI-MS-06 — references

Normative and informative references, and related standards in the same category.

Document identifier
CEI-MS-06/7
Series
Methodological standard
Version
1.0
Published
22 Apr 2023
Last reviewed
22 Oct 2023
Next review
22 Oct 2026
Identifier
10.71829/cei.meth.6
Certainty
High
Cycle
2023 Q2
Category
Microbiological quality

§7References

§7.1Normative references

The following are normative for this standard: compliance with the standard requires compliance with them[1,2,3,4,5].

§7.2Informative references

This standard cites no informative reference.

§7.3Related standards

  • CEI-MS-05 — Bacterial endotoxin determination in peptide preparations intended for parenteral use

Numbered reference list

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. United States Pharmacopeial Convention. General Chapter ⟨71⟩ Sterility Tests. United States Pharmacopeia — National Formulary (USP–NF) 2024;USP 2024 Issue 1. identifier not held by the Institute
  2. United States Pharmacopeial Convention. General Chapter ⟨85⟩ Bacterial Endotoxins Test. United States Pharmacopeia — National Formulary (USP–NF) 2024;USP 2024 Issue 1. identifier not held by the Institute
  3. United States Pharmacopeial Convention. General Chapter ⟨795⟩ and ⟨797⟩ Pharmaceutical Compounding — Nonsterile and Sterile Preparations. United States Pharmacopeia — National Formulary (USP–NF) 2023;USP 2023 Issue 2. identifier not held by the Institute
  4. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute
  5. World Health Organization. WHO Expert Committee on Specifications for Pharmaceutical Preparations — Fifty-seventh report. WHO Technical Report Series 2023;No. 1044. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.